| abstract |
The invention relates to potassium salts of tenatoprazole, represented by the following general formula, which consist of an equimolar mixture of enantiomers of R and S configuration crystallizing in the form of a conglomerate, said salts being chosen from the potassium salt dihydrate tenatoprazole potassium dimethanolate, tenatoprazole potassium diethanolate and tenatoprazole potassium ethylene glycolate.The invention also relates to a pharmaceutical composition comprising such a salt, as well as the use of such a salt. . |